Preclinic Evaluation of a Vitamin D Analog in Vitamin D 24-hydroxylase Deficiency

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Preclinical evaluation of a vitamin D analog for the treatment of vitamin D 24-hydroxylase using fibroblast from patients with CYP24A1 mutation.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• biallelic mutation in CYP24A1

• consent

Locations
Other Locations
France
Arnaud Molin
RECRUITING
Caen
Time Frame
Start Date: 2022-07-17
Estimated Completion Date: 2027-07-01
Participants
Target number of participants: 30
Treatments
Experimental: patients with CYP24A1 mutation
Related Therapeutic Areas
Hypercalcemia
Milk-Alkali Syndrome
Sponsors
Leads: University Hospital, Caen

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

Efficacy of Vitamin D Supplementation in Females With Polycystic Ovary Syndrome: a Randomized Open Label Delayed-start Design

Efficacy of Vitamin D Supplementation in Females With Polycystic Ovary Syndrome: a Randomized Open Label Delayed-start Design

Enrollment Status: Recruiting
Publish Date: February 18, 2025
Intervention Type: Other, Drug
Study Phase: Phase 1

Hypercalcemia After Paraffin Oil Injection: Aetiology, Pathogenesis and Possible Treatment Options

Hypercalcemia After Paraffin Oil Injection: Aetiology, Pathogenesis and Possible Treatment Options

Enrollment Status: Recruiting
Publish Date: April 06, 2025
Intervention Type: Diagnostic test

Sorveglianza Attiva Dei Tumori Renali T1a Uguali o Inferiori a 2 cm

Sorveglianza Attiva Dei Tumori Renali T1a Uguali o Inferiori a 2 cm

Who is this study for: Patients over 50 with small renal masses
Enrollment Status: Recruiting
Publish Date: February 11, 2020
Intervention Type: Other
Study Phase: Not Applicable
View All